Life Science & Biotech Companies in Cambridge

Digital cognitive assessment and CNS clinical trial software platform

Cambridge Cognition provides digital cognitive assessment and clinical trial technology for central nervous system drug development. Its validated computerised tests measure…

Small molecule inhibitors targeting somatic expansion in neurodegeneration

LoQus23 Therapeutics is a biotechnology company developing oral small molecule inhibitors of DNA mismatch repair for the treatment of Huntington's disease and other triplet repeat…

Genomics and biodata research campus near Cambridge

Wellcome Genome Campus is a 125-acre research campus in Hinxton, Cambridgeshire, owned by Wellcome. It is home to the Wellcome Sanger Institute, EMBL-EBI, Wellcome Connecting…

3D multi-omics platform for genetically validated drug target discovery

Enhanced Genomics is a biotechnology company developing a proprietary 3D multi-omics platform that maps genome-wide chromatin interactions to identify genetically validated drug…

Bioactive molecule delivery technologies for cell culture and therapeutics

Cell Guidance Systems is a biotech and reagents company developing technologies for the delivery of bioactive molecules, with applications in cell biology research, drug…

Integrated bioprocessing platform for biologics development and manufacture

Biologic Technologies is a developer of intelligent bioprocessing platforms for biologics development and manufacturing. Its platform integrates complete biological workflows into…

First-in-class small molecule inhibitors of RNA-modifying enzymes

STORM Therapeutics is a clinical-stage biotechnology company pioneering the field of RNA epigenetics, developing small molecule inhibitors of RNA-modifying enzymes as a new class…

Targeted protein degradation platform for neurodegenerative disease

TRIMTECH Therapeutics is a biotechnology company developing small-molecule degraders that selectively remove disease-causing protein aggregates while preserving the functional,…

Rapid diagnostic platforms for infectious disease and consumer testing

Sapphiros is a privately held diagnostics portfolio company backed by KKR and Neoenta. UK operations include Biocrucible, a molecular diagnostics company developing ultra-rapid…

Life sciences membership organisation and industry network

One Nucleus is a not-for-profit life sciences and healthcare membership organisation headquartered in Cambridge, serving over 400 member companies across the Cambridge/London…

Tunable covalent chemistry platform for neurodegenerative disease

Dunad Therapeutics is a drug discovery biotech developing small molecule therapies for neurodegenerative diseases including ALS, frontotemporal dementia, and Parkinson's disease.…

Antibody therapy to deplete amyloid deposits in ATTR cardiomyopathy

Immutrin is a biotechnology company developing an engineered antibody therapeutic designed to actively remove amyloid deposits from tissues in patients with amyloidosis. Its lead…